FDA Considers Extending Roche’s Accutane Deadline

WASHINGTON - The tens of thousands of Americans who take Accutane to treat their severe acne may gain additional time to register with a program designed to limit use of the birth defect-causing drug by pregnant women, health officials said Friday.